The Pennsylvania biotech company CSL Behring says it is on track to file for approval of its hemophilia B gene therapy by the end of June after releasing pivotal data showing statistical superiority ...
CSL, the Australian biotechnology company behind CSL Behring in King of Prussia, plans to cut up to 15 percent of its global workforce, or about 3,000 jobs worldwide, writes John George for the ...
- 4- and 5-gram ZEMAIRA® vials may reduce the number of vials necessary for reconstitution, thereby providing convenience and lowering package waste KING OF PRUSSIA, Pa., Jan. 2, 2024 /PRNewswire/ -- ...
-- This milestone underscores CSL Behring's promise to develop and deliver a truly unique portfolio of patient-focused therapies for people with rare and serious medical conditions The BLA is ...
Global biotherapeutics leader CSL Behring and renowned portrait photographer Rankin have teamed up to launch ‘Portraits of Progress’, a multi-media campaign showcasing the stories and experiences of ...
Narrow-moat CSL reiterated fiscal 2025 guidance for constant-currency group net profit after tax before amortization, or NPATA, of USD 3.2 billion to USD 3.3 billion, implying 10%-13% growth on fiscal ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen by an independent group of researchers. The Nature Index provides absolute Count of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results